HEALTHCARE DEAL ADVISORY
Where healthcare deals get done.
Crimson Ridge Partners is a healthcare deal advisory firm focused on creating value through high-impact transactions across sectors, including pharmaceuticals, biologics, medical devices and digital health.
We are not generalist advisors; we are focused solely on healthcare. In a complex and rapidly evolving industry, Crimson Ridge Partners delivers clarity, momentum, and results when transactions matter most.
Healthcare only
Focused exclusively on pharmaceutical and healthcare transactions.
Decades of experience
Combined 50 years of healthcare leadership across markets and business models.
Cross-border reach
Europe, Middle East and Africa, and South-East Asia. Selected support available for Americas and Asia-Pacific.
Partner-led throughout
Direct senior involvement from mandate definition to closing.
FOCUS AREAS
Mandates built around transactions, not generic advice.
We combine strategic judgment, opportunity origination and transaction execution within a single senior-led mandate.
I.
Portfolio strategy and asset sourcing
II.
Licensing and distribution
III.
Acquisitions and divestments
IV.
Commercial strategy and market entry
V.
Strategic transactions
OUR APPROACH
One accountable lead partner from start to finish.
Mandate definition
and scoping
1
Target identification
and prioritization
2
Outreach and
screening
3
Due diligence and
structuring
4
Signing and
closing
5
WHERE WE OPERATE
Healthcare expertise across sectors and borders.
Pharmaceuticals
(Rx, OTC, VAM/505b2)
Biologics
(incl. biosimilars)
Medical
devices
Digital health
solutions
Healthcare
services
Geographic reach
Headquartered in Dubai, U.A.E.
Focus on Europe, Middle East and Africa, and South-East Asia
Selected mandate support available for Americas and Asia-Pacific
Established relationships and expertise across developed and emerging markets
Advisors first.
Dealmakers second.
Partners always.
NEXT STEP
Reviewing your commercial or portfolio strategy?
Considering a licensing opportunity, acquisition or strategic partnership?
Evaluating an expansion into new markets, channels or therapeutic areas?
Speak directly with the partners about the opportunity, the market and the practical path forward.